Danfeng Xu

Second Military Medical University, Shanghai Jiao Tong University

Papers

Total Citations

H-Index

About

Danfeng Xu is a leading urologic surgeon and researcher whose work has significantly advanced the surgical management of prostate cancer. His primary research focuses on optimizing surgical techniques and perioperative care for radical prostatectomy, with key contributions in comparing robot-assisted and open surgical approaches. In his highly cited 2014 systematic review and meta-analysis, Xu provided critical evidence on the comparative effectiveness of robot-assisted versus open retropubic radical prostatectomy, helping guide surgical decision-making. His impactful 2020 study on enhanced recovery after surgery (ERAS) pathways demonstrated that structured perioperative protocols can significantly improve outcomes and reduce costs for patients undergoing minimally invasive radical prostatectomy. With over 30 citations across his most influential works, Xu's research has shaped modern urologic practice by emphasizing both surgical precision and comprehensive patient care. His work on ERAS implementation represents a notable achievement in translating evidence-based protocols into clinical practice, ultimately improving recovery experiences for prostate cancer patients.